deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT03198000

A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

A Single-Center, Randomized, Controlled Study to Evaluate the Efficacy of Two Investigational OTC Eye Drops in Healthy Adults With Red Eye

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)

Conditions Ophthalmic Solutions
Interventions F# 13418-148 Eye Drops F# PF-004390 Eye Drops F#13418-158 Eye Drops
Updated 12 times since 2017 Last updated: Apr 27, 2023 Started: Jun 28, 2017 Primary completion: Jul 21, 2017 Completion: Jul 21, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Ophthalmic Solutions and is currently completed. Johnson & Johnson Consumer Inc. (J&JCI) leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshotNot Yet Recruiting~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshotActive Not Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotCompleted~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshotCompleted~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jun 2023 · 5 months · monthly snapshotCompleted~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jun 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Jun 2023 [monthly]

    Completed PHASE3

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

▶ Show 7 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE3

  2. Oct 2018 — Jan 2021 [monthly]

    Completed PHASE3

  3. Sep 2018 — Oct 2018 [monthly]

    Completed PHASE3

  4. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE3

  5. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  6. Aug 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE3

    Status: Not Yet Recruiting → Active Not Recruiting

  7. Jul 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johnson & Johnson Consumer Inc. (J&JCI)
Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations